Intralesional interleukin-2 augmentation therapy in treatment-refractory melanoma

Dermatol Ther. 2022 Nov;35(11):e15853. doi: 10.1111/dth.15853. Epub 2022 Oct 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunotherapy
  • Injections, Intralesional
  • Interleukin-2
  • Melanoma* / drug therapy
  • Skin Neoplasms* / drug therapy

Substances

  • Interleukin-2